Azenta to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference

CHELMSFORD, Mass., Aug. 11, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 16, 2022.

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. As of December 1st, the company changed its name and ticker to Azenta, Inc. (Nasdaq: AZTA) from Brooks Automation, Inc, (Nasdaq: BRKS).

Azenta is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

INVESTOR CONTACT:Sara SilvermanHead of Investor Relations978.262.2635IR@azenta.com

Sherry DinsmoreAzenta Life Sciences978.262.2400sherry.dinsmore@azenta.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-7th-annual-needham-virtual-med-tech--diagnostics-1x1-conference-301604577.html

SOURCE Azenta, Inc.